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 Congenital cataract is a clinically and genetically highly
heterogeneous eye lens disorder. Its incidence is estimated to
be 2.2 to 2.49 per 10,000 live births [1,2]. One-third of the
cases show a positive family history [3], usually suggesting
an autosomal dominant mode of inheritance [4,5]. It may oc-
cur as an isolated eye anomaly or as a part of a multisystem
syndrome.
Lens sutures are the lines at anterior and posterior poles
of the embryonic lens nucleus where growing secondary fiber
cells from the equator migrate and meet. Sutures start to ap-
pear at the eighth to ninth weeks of fetal life. The addition of
more cell layers till birth forms the suture plane with a sym-
metrical Y-pattern and a symmetrical inverted Y-pattern at re-
spective anterior and posterior sections of the lens [6]. After
birth, suture formation becomes complex and irregular due to
fundamental changes that occur in the lens fibers differentia-
tion [7]. Abnormal development of sutures has been found to
be associated with specific types of cataracts [8]. A cataract is
classified as sutural when the opacity affects the whole or part
of either one or both sutures of the lens. So far, sutural cata-
ract, in association with other lens opacities, has been mapped
at 1p36 [9], 3q (BFSP2) [10-12], 15q [13], 16q22 (HSF4) [14],
17q (CRYBA1) [15], 22q (CRYBB1, CRYBB2) [16,17], and in
syndromal cases at 14q13-21 (craniolenticulosutural-dyspla-
sia syndrome) [18] and on the X chromosome (Nance-Horan
syndrome gene, NHS) [19].
Hereditary hyperferritinemia-cataract syndrome (HHCS;
OMIM 600886) is an autosomal dominant disorder character-
ized by early onset bilateral nuclear cataract in association
with a manyfold increase in L-ferritin levels in blood serum
and in tissues such as lymphocytes, liver, and lenses in the
absence of iron overload [20-22]. Under normal conditions,
synthesis of ferritin is regulated at the translational level by
iron availability. During low iron status, high affinity interac-
tion between trans-acting iron regulatory proteins (IRPs) and
the iron responsive element (IRE) in the 5'-untranslated re-
gion (5'-UTR) of L-ferritin mRNA prevents iron sequestra-
tion by blocking ferritin translation. In cases of abundant cel-
lular iron availability, formation of 4Fe-4S clusters within IRPs
inhibits their binding to the IRE and allows abundant ferritin
translation [20,22-24]. So far, 28 different mutations have been
found in the 5'-UTR of the L-ferritin gene, resulting in re-
duced affinity for IRPs and hence increased synthesis of L-
ferritin.
We came across a four generation family affected with
bilateral congenital cataract at the Dr. Daljit Singh Eye Hos-
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Purpose: The molecular characterization of 27 members of an Indian family, with 13 members in four generations,
affected with Y-sutural congenital cataract.
Methods: Detailed family history and clinical data were collected. A genome-wide scan by two-point linkage analysis
using more than 400 microsatellite markers in combination with multipoint lod score and haplotype analysis was per-
formed. Mutation screening was carried out in the candidate gene by bi-directional sequencing of amplified products.
Results: A maximum two-point lod score of 6.37 at θ=0.00 was obtained with marker D19S879. Haplotype analysis
placed the cataract locus to a 5.0 cM region between D19S902 and D19S867, in close proximity to the L-ferritin light
chain gene (FTL) on chromosome 19q13.3. Hematological tests in two affected individuals showed very high levels of
serum ferritin without iron overload leading to the diagnosis of hyperferritinemia-cataract syndrome. Mutation screening
in FTL identified a G>A change at position 32 (c.-168G>A) in a highly conserved 3 nucleotide motif that forms a loop
structure in the iron responsive element (IRE) in the 5'-untranslated region (5'-UTR). This nucleotide alteration was
neither seen in any unaffected member of the family nor found in 50 unrelated control subjects.
Conclusions: The present study is the first report of a Y-sutural congenital cataract mapping to 19q13.3. The mutation
observed in FTL in this family highlights the phenotypic heterogeneity of the disorder in relation to the genotype as the
identical mutation (32 G>A) has previously been reported in two Italian families with entirely different phenotypes. It is
also the first report of hereditary hyperferritinemia-cataract syndrome in a family of Indian origin.
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pital, Amritsar, India. A genome-wide scan by two-point link-
age analysis using more than 400 microsatellite markers and
further multipoint and haplotype analysis placed the cataract
locus within a 5.0 cM region between markers D19S902 and
D19S867 on chromosome 19q13. Since FTL lies within the
mapped interval, and because of its association with HHCS,
hematological tests were performed in two patients. These
indicated high levels of ferritin in the serum without iron over-
load. Sequencing of FTL showed a G>A change in the 5'-UTR
at position 32 from the transcription start site, in a highly con-
served three-nucleotide motif that forms the IRE bulge. This
is the first report of HHCS in a family of Indian origin.
METHODS
Family description:  The index case, a five-year-old child, was
diagnosed as having bilateral sutural cataract (Figure 1). The
family history revealed 13 affected members in four genera-
tions (Figure 2). The detailed ophthalmological examination,
which included slit lamp examination and photography of af-
fected lenses, performed on 27 members of the family, re-
vealed 13 members who were bilaterally affected (some had a
history of cataract extraction in childhood) and 14 individuals
(including four spouses) who were unaffected.
Phenotype description:  In all affected individuals the
opacities were confined to the Y-sutures (Figure 1). However,
this sutural cataract was peculiar in appearance as the opaci-
ties were flat and wide, nonuniform in width, and appeared to
be composed of small round and oval segments, superimposed
upon each other near the edges. It appeared like a pile of coins.
This coin-like character was seen in the primary Y-sutures and
in its divisions. Both anterior and posterior lesions were simi-
lar in appearance. In optical sections, the location of the opaci-
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Figure 1. Photograph (3-D lens) of a patient taken through a slit lamp.
The phenotype is Y-sutural as both the anterior and posterior inverted
Y-sutures are severely affected. No nuclear component is involved,
and there is no opacity evident in the cortex of the lenses. The opac-
ity appears to be made up of a compilation of coins.
Figure 2. Haplotype analysis of a sutural cataract family with chromosome 19 markers.  Sequence of markers is from centromere to telomere.
Blackened bars indicate the affected haplotype. Inferred haplotypes are in parentheses. Recombination events seen in individuals II:2 and IV:1
place the disease gene locus between markers D19S902 and D19S867.
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ties was between the nucleus and the surrounding cortex, at
some distance from the anterior and posterior capsules. There
were no additional opacities in the lens. The nucleus and the
periphery were clear. In short, this phenotype may be described
as a Y-sutural cataract composed of coin-like segments.
Genotyping and linkage analysis:  Informed consent was
obtained from each individual studied. This study was ap-
proved by the ethics review board of the Guru Nanak Dev
University, consistent with the provisions of the Declaration
of Helsinki. Blood was drawn and DNA isolated by standard
methods. A genome-wide search with more than 400
microsatellite markers (Genethon linkage map) [25] was done
on DNA samples of all 27 ophthalmologically examined indi-
viduals (13 affected and 14 unaffected, including four spouses).
Microsatellites were amplified in singleplex reactions by touch-
down PCR (MJ-Research, Watertown, MA) using fluorescent-
labeled primers following standard methods. Polymerase chain
reaction (PCR) products were pooled and denatured at 95 °C
for 1 min and electrophoresed on 96-capillary automated DNA
sequencers (MegaBACE 1000, Amersham, Freiburg, Ger-
many). Genotyping was done with the use of the software
Genetic Profiler version 1.5 (Amersham). Autosomal domi-
nant inheritance with a disease gene frequency of 0.0001 and
complete penetrance of the trait was assumed. Recombina-
tion frequencies were considered equal between males and
females. Two-point linkage analysis was carried out with
MLINK from the LINKAGE program package [26], and
multipoint analysis was carried out using Genehunter [27].
Autosomal dominant inheritance was assumed with a reduced
penetrance of 98% and a phenocopy rate of 0.5%.
Hematological tests:  After informed consent was ob-
tained, fresh blood was drawn from two affected individuals
(II:9, III:12; Figure 2) and sent to the Clinical Reference Labo-
ratory (SRL Ranbaxy, Mumbai Maharashtra (MH), India) for
measuring serum ferritin, serum iron, total iron binding ca-
pacity (TIBC), and transferrin levels.
Mutation analysis:  Four pairs of primers (Table 1) were
designed from intronic regions to amplify the coding regions
and splice sites of FTL (GenBank NM_000146.3 and
NC_000019.8). Genomic DNA from two affected and one
unaffected individuals were amplified. Amplification was car-
ried out in 25 µl reactions containing 100 ng genomic DNA,
10 pmoles each of forward and reverse primers, 200 µM dNTP,
10X PCR buffer, 1.5 mM MgCl2, and 0.25 U Taq DNA poly-
merase (AmpliTaq Gold; ABI, Foster City, CA). Amplifica-
tion conditions consisted of an initial denaturation step at 95
°C for 5 min, followed by 35 cycles consisting of a denatur-
ation step at 95 °C for 45 s, annealing step for 30 s at 57 °C,
and an extension at 72 °C for 45 s, followed by a final exten-
sion step at 72 °C for 10 min. PCR products were purified
using a PCR product purification kit (QIAquick; Qiagen,
Valencia, CA). Purified PCR products were sequenced
bidirectionally using the ABI BigDye™ Terminator Cycle
Sequencing Ready Reaction Kit version 3.1 (ABI) for a 10 µl
final volume, containing 5.0 µl purified PCR product, 4.0 µl
BigDye Terminator ready reaction mix and 3.2 pmoles of prim-
ers. Cycling conditions were 95 °C for 2 min, 25 cycles at 95
°C for 30 s, 52 °C for 15 s, and 60 °C for 4 min. The sequenc-
ing reaction products were purified by the isopropanol pre-
cipitation method (ABI protocol), suspended in 10 µl of
formamide (Hi-Di-Formamide; ABI), denaturated at 95 °C for
5 min, and electrophoresed on an ABI 3100 Genetic Analyzer.
Sequencing results were assembled and analyzed using the
SeqMan II program of the Lasergene package (DNA STAR
Inc., Madison, WI).
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TABLE 1. PRIMER SEQUENCES FOR AMPLIFICATION OF EXONIC REGIONS
OF FERRITIN LIGHT CHAIN POLYPEPTIDE (FTL)
                                     PCR       Annealing
                                   product    temperature
Exon       Sequence (5'-3')       size (bp)      (°C)
----   ------------------------   ---------   -----------
 1F    CCTATGTGCTCCGGATTGGTCA        549          57
 1R    GTAAACAGAGGGCGGAGTCC
 2F    CACCTCCGGCCCTCACTGC           385          57
 2R    TGAGTTCGGTCTTGTGAGCCCT
 3F    GGACAGGGTGCGGAGAGTGATAAA      361          57
 3R    TTCCTTCAGAGCCTCATTTCACAC
 4F    TCCTTCAGAGCCTCATTTCACACC      445          57
 4R    TGGTGTGGAAGATGAGGTGGGAT
Shown are primers for PCR (polymerase chain reaction) and sequenc-
ing of FTL.
TABLE 2. TWO-POINT LOD SCORES FOR LINKAGE BETWEEN THE DISEASE LOCUS AND CHROMOSOME 19 MARKERS
                                            LOD Scores at θ
          IMD    ----------------------------------------------------------------------
Marker    (cM)    0.00    0.001   0.01    0.05    0.10    0.15    0.20    0.30    0.40
-------   ----   ------   -----   -----   -----   -----   -----   -----   -----   -----
D19S902   2.7    -5.356   0.440   1.388   1.854   1.851   1.710   1.503   0.984   0.430
D19S879   0.1     6.370   6.360   6.267   5.844   5.291   4.708   4.091   2.740   1.230
D19S604   2.2     2.249   2.245   2.210   2.051   1.841   1.617   1.383   0.890   0.402
D19S867   0.5     2.393   2.462   2.785   3.030   2.900   2.641   2.313   1.521   0.607
D19S907   0.1     3.084   3.080   3.046   2.874   2.623   2.338   2.022   1.303   0.510
D19S904   0.0     1.219   1.216   1.192   1.085   0.947   0.806   0.661   0.370   0.114
D19S246   4.0     3.201   3.195   3.137   2.873   2.532   2.178   1.809   1.034   0.305
D19S397   4.0     1.343   1.489   2.196   2.965   3.061   2.908   2.631   1.835   0.800
This table summarizes the two-point LOD scores for chromosome 19q13.3 around the FTL locus. The highest observed LOD score was 6.37
at θ=0.0 for marker D19S879. Intermarker distances (IMD) are based on the Genthon linkage map [25].
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RESULTS
Linkage analysis:  In a genome-wide scan using more than
400 markers, we initially obtained positive two-point lod scores
of 1.977 at θ=0.001 with marker D19S178 and of 3.201 at
θ=0.000 with marker D19S246. Further analysis with more
markers in this region on chromosome 19 gave a maximum
lod score of 6.37 at θ=0.000 with marker D19S879 (Table 2).
Multipoint analysis carried out with more markers from this
region also supported the linkage with the same maximum
lod score of 6.37 with D19S879 (data not shown).
Haplotype analysis:  Haplotypes were constructed for the
markers analyzed on chromosome 19 (Figure 2). Recombina-
tion events were detected in affected individuals II:2, III:8,
and IV:1. Individual II:2 was recombinant at marker D19S902,
individual III:8 was found to be recombinant at marker
D19S397, while individual IV:1 was found to be recombinant
at marker D19S902, as seen in his mother and grandmother,
and markers telomeric to D19S867. Cosegregation was ob-
served in all affected individuals for markers D19S879 and
D19S604, indicating that the disease locus lies in this inter-
val. The cataract locus was thus mapped to a 5.0 cM region
between D19S902 and D19S867, which corresponds to a re-
gion on chromosome 19q13.3.
Hematological analysis:  The candidate gene FTL lies
within the mapped critical interval and is pathogenetically in-
volved in HHCS. Therefore, we performed hematological
analyses in two affected individuals II:9 and III:12 (Figure 2).
They showed very high serum ferritin levels (2283.1 and
1638.7 µg/l, respectively; Table 3) in comparison to the con-
trol levels (range: 22-322 µg/l). Serum iron, TIBC, and its
relative saturation, serum transferrin, and transferrin satura-
tion levels were within normal range in patient II:9. In patient
III:12, the levels of TIBC were slightly higher and the trans-
ferrin saturation lower than in the controls. These findings
indicated that these individuals had HHCS.
Mutation analysis:  Sequencing of FTL in two affected
individuals (II:9 and III:12) showed a heterozygous change
G>A (Figure 3) at position 32 from the transcription start site
(c.-168G>A). This position belongs to the IRE in the 5'-UTR
of FTL. All other affected family members tested also showed
this nucleotide change. This alteration was neither seen in any
unaffected member of the family nor found in 50 unrelated
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TABLE 3. HEMATOLOGICAL DATA OF THE CATARACT PATIENTS INVESTIGATED
             Serum       Total iron binding                                   Serum
              iron        capacity (µg/dl)       Transferrin      Serum      ferritin
             levels    -----------------------   saturation    transferrin    levels
Patient ID   (µg/dl)   unsaturated   saturated       (%)         (mg/dl)     (µg/dl)
----------   -------   -----------   ---------   -----------   -----------   --------
    73         76         249.0         325         23.4           261        2283.1
    85         37         377.0         414          8.9           307        1638.7
----------   -------   -----------   ---------   -----------   -----------   --------
Reference    35-140      130-375      245-400       13-45        200-400      22-322
range
Shown here are the serum iron, total iron binding capacity, transferrin saturation, and serum ferritin levels in patients with congenital cataract.
Very high levels of serum ferritin (1638.7 and 2283.1 µg/l) were observed in patients as compared to the reference range.
Figure 3. DNA sequence of a
part of ferritin light chain
polypeptide in an unaffected
and an affected individual.
Electropherogram showing a
part of the IRE (iron respon-
sive element) sequence of FTL
(ferritin light chain polypep-
tide) in an unaffected (forward
and reverse strands) and an af-
fected family member (for-
ward and reverse strands; in-
dividuals III:3 and IV:1). A het-
erozygous change G>A in the
5'-untranslated region (5'-
UTR) at position 32 from the
transcription start (c.-168G>A)
is indicated by arrows.
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control subjects (data not shown). Apart from this, a known
polymorphic change, TTG to CTG in codon 55 in exon 2 of
FTL (both coding for leucine), was observed in affected and
unaffected individuals (data not shown).
DISCUSSION
 This study is the first report of a Y-sutural congenital cataract
mapping to 19q13.3. The opacities were present bilaterally
since birth in the affected members who underwent cataract
surgery during the first decade of life. Both Y-sutures were
severely affected without involvement of any other lens com-
ponents. The lens nucleus, cortex, and periphery were clear.
Two affected individuals, in whom hematological tests were
undertaken, showed very high levels of serum ferritin without
iron overload, indicating HHCS. This was confirmed by mu-
tation screening in FTL showing a disease-causing G>A mu-
tation in the 5'-UTR at position 32 of exon 1 in all affected
individuals. This mutation, also known as the Pavia-1 muta-
tion, has been reported in two Italian families in association
with nuclear and bilateral cataracts, respectively [24,28]. The
Indian family described here with an identical mutation dif-
fers from the Italian families in having an entirely different
cataract phenotype, in the age of cataract onset, and in the
levels of serum ferritin. To our knowledge, this is the first
report of HHCS in a family of Indian origin, after previous
reports of HHCS from Europe, Australia, and the USA.
So far, at least 28 mutations have been reported in the 5'-
UTR of FTL; some occurred in the loop (5'-CAGUG-3' at
positions 39 to 43), while others affected the bulge (5'-UGC-
3' at positions 31 to 33) or stem of the IRE. Most of these
mutations alter the structure of the IRE thus either abolishing
or significantly decreasing the affinity binding of IRPs. This
results in constitutive upregulation of L-ferritin in the serum
and body tissues [29,30]. It has been reported that nucleotide
32G is important for IRE function in vivo and for high affin-
ity RNA-protein interaction in vitro [31]. On the basis of a
thermodynamic analysis, it has been revealed that mutations
in the IRE either change its stability and secondary structure
or disrupt the IRP-IRE recognition site [32].
Cazzola et al. [24] tried to establish a relationship be-
tween the identified mutations, the serum-ferritin levels, and
the severity of the cataract. They observed that mutations
within the IRE loop sequence resulted in the highest ferritin
levels (1200-2700 µg/l) with severe cataracts (marked loss of
visual acuity in the first decade with some individuals requir-
ing cataract surgery). Mutations in the IRE bulge caused mild
cataract (visual acuity corrected with the use of appropriate
eye glasses) with ferritin levels being in the range of 950-
1900 µg/l. The nucleotide changes in the lower stem of the
IRE resulted in lowest levels of ferritin (350-650 µg/l) with
asymptomatic cataract (no effect on visual acuity). These find-
ings were confirmed by Mumford et al. [22], who showed
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TABLE 4. MUTATIONS IN IRE BULGE (5'-UGC-3' AT POSITIONS 31 TO 33) OF FTL POLYPEPTIDE IN RELATION TO FERRITIN LEVELS
AND CATARACT TYPE
                           Serum
Nucleotide    Origin     ferritin       Cataract           Cataract
  change     of family    (µg/l)        diagnosis        type/severity      Reference
----------   ---------   ---------   ---------------   ------------------   ---------
  32G>C      USA          793-2350   Childhood         Bilateral*             [38]
  32G>C      Italy       1270-1450   18 months         Bilateral*             [39]
  32G>C      English     2000-2898   9 weeks           Bilateral*             [40]
  32G>T      Paris       1025-2264   Late childhood/   Mild cataract*         [31]
                                     adulthood
  32G>T      Paris        734-1362   3-40 years        Pulverulent            [34]
  32G>T      Australia   1554        2 years           Bilateral*             [41]
  32G>A      Italy        950-1900   Childhood         Nuclear                [24]
                                                       (severe cataract)
  32G>A      Italy       1100-1275   7-18 years        Bilateral*             [28]
                                                       mild to severe
  32G>A      India       1638-2283   At birth          Severely affected     Present
                                                       Y-sutural, without    study
                                                       nuclear opacities
  33C>T      Spain        989-1770                     Mild bilateral*        [33]
                                                       cataract during
                                                       1st decade, except
                                                       in proband
  33C>T      Italy        653-1392   9-18 years                               [34]
  33C>T      USA         1300-1440   5 years           Bilateral*             [36]
  33C>A      Paris       1000                                                 [42]
This table shows the identified mutations in the bulge region of the iron responsive element (IRE) in the 5' UTR (untranslated region) of FTL
(ferritin light chain polypeptide) in relation to origin of family, serum ferritin levels, age at diagnosis of cataract, and its phenotype. In the
“Nucleotide change” column, the numbering starts from the transcription start site (GenBank NM_000146.3). The asterisk indicates that no
exact phenotype of opacity was described by the authors.
97
that mutations near the apex of the IRE resulted in higher se-
rum ferritin concentrations and denser cataracts, and by Balas
et al. [33], who observed mild cataracts associated with muta-
tions in the bulge region. However, not all mutations reported
in this region follow a simple genotype-phenotype correla-
tion (Table 4).
Balas et al. [33], Girelli et al. [34], and Perez de Nanclares
et al. [35] reported that lens opacities in their HHCS patients
were not detectable at birth and manifested in an age-depen-
dant manner. In the present family, lens opacities were promi-
nent since birth, with both Y-sutures being severely affected.
The patients needed early cataract surgery within their first
decade of life.
A 5-20 fold higher accumulation of L-ferritin in serum
and tissues has been observed in HHCS cases, which has no
evident effect on the body iron status but is often associated
with early onset cataract. Two mechanisms have been pro-
posed for this association of cataract with hyperferritinemia.
A change in the L- and H-subunit ratio of ferritin composition
may cause an increase in free iron and reactive oxygen, re-
sulting in oxidative damage of the lens and cataract forma-
tion. Alternatively, cataract may be the result of lens protein
aggregation caused by intracellular ferritin. Thus, Brooks et
al. [36] reported light diffracting deposits of ferritin crystals
in HHCS cataractous lenses, and Mumford et al. [37] found
that HHCS lenses contain crystalline deposits of L-ferritin.
However, Levi et al. [21] reported that ferritin in HHCS lenses
was readily soluble without forming any aggregates in vitro
and suggested that ferritin precipitation is not the primary cause
of lens opacity.
In summary, large intragenic heterogeneity and pheno-
typic variability with respect to severity and type of cataract,
age of onset, and serum ferritin levels has been observed in
HHCS. This is illustrated in our patients and in those from
two Italian families [24,28]. They share the same FTL muta-
tion (32G>A) but show clear differences in the type of cata-
ract, the age of onset, and the serum ferritin levels. Thus, apart
from the pathogenetic mutation, other genetic or even envi-
ronmental factors must play a significant role in disease mani-
festation. The analysis of serum ferritin levels is therefore
mandatory in individuals with congenital cataract to establish
the correct diagnosis HHCS.
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